Source:http://linkedlifedata.com/resource/pubmed/id/20668023
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-9-22
|
pubmed:abstractText |
Aromatase, a key enzyme of estrogen biosynthesis, is transcriptionally regulated by many growth factors. IGF-I enhances aromatase activity in a variety of cells, but the mechanism of action has not been determined. We herein report our finding of a novel mechanism of action for IGF-I. IGF-I enhanced the dexamethasone (DEX)-induced aromatase activity by 30% in serum-starved THP-1 cells. The increase was associated with a corresponding increase in the level of aromatase protein but not with any change in the mRNA level. Metabolic labeling experiments revealed that IGF-I inhibited the degradation of aromatase. We identified pepstatin A as the most effective inhibitor of aromatase degradation by in vitro assay. Using a nontoxic concentration of pepstatin A, we examined IGF-I's action on aromatase distribution in microsomes and lysosomes. In the presence of pepstatin A, DEX caused an increase in the amount of aromatase in both microsomes and lysosomes, and IGF-I attenuated the DEX-induced accumulation of aromatase in lysosomes and, conversely, enhanced its accumulation in the microsomes. The addition of serum abolished the IGF-I-induced changes. The transport from microsome to lysosome was fluorescently traced in cells using a recombinant aromatase. IGF-I selectively reduced the aromatase signal in the lysosomes. Finally, we observed that IGF-I enhanced the aromatase activity by 50% as early as 1 h after treatment; furthermore, rapamycin, an enhancer of autophagy, completely negated the effect of IGF-I on the enzyme. These results indicate that IGF-I enhances aromatase by the inhibition of autophagy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aromatase,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Pepstatins,
http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/pepstatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1945-7170
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
151
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4949-58
|
pubmed:meshHeading |
pubmed-meshheading:20668023-Aromatase,
pubmed-meshheading:20668023-Autophagy,
pubmed-meshheading:20668023-Cell Line, Tumor,
pubmed-meshheading:20668023-Dexamethasone,
pubmed-meshheading:20668023-Down-Regulation,
pubmed-meshheading:20668023-Enzyme Activation,
pubmed-meshheading:20668023-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:20668023-Humans,
pubmed-meshheading:20668023-Insulin-Like Growth Factor I,
pubmed-meshheading:20668023-Lysosomes,
pubmed-meshheading:20668023-Pepstatins,
pubmed-meshheading:20668023-Protease Inhibitors,
pubmed-meshheading:20668023-Protein Processing, Post-Translational,
pubmed-meshheading:20668023-Protein Stability,
pubmed-meshheading:20668023-RNA, Messenger,
pubmed-meshheading:20668023-Up-Regulation
|
pubmed:year |
2010
|
pubmed:articleTitle |
Insulin-like growth factor I enhances the expression of aromatase P450 by inhibiting autophagy.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Kanazawa University Graduate School of Medicine, Kanazawa 920-0934, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|